Billionaire Profile
August Troendle
Global Rank
#1099

Image: Unsplash Contributor | Unsplash License | via Unsplash

August Troendle

CEO, Pharmaceutical services
UNITED STATES
Real-Time Net Worth
$3.939B
Estimated based on Pharmaceutical services stock value as of April 21, 2026
+1.14% (24h)
Age
70
Source
Pharmaceutical services
Industry
Healthcare
Citizenship
UNITED STATES

Biography

August Troendle, a medical doctor, is the CEO and Chairman of Medpace, a leading clinical research organization (CRO). His estimated net worth is $3.5 billion as of March 25, 2026. Troendle's wealth stems from his founding of Medpace in 1992, which provides clinical trial services to pharmaceutical and biotechnology companies. His career includes experience as a Medical Review Officer at the FDA and leadership roles at Sandoz (Novartis). Troendle's strategic vision has propelled Medpace to global recognition.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

August Troendle, born January 1, 1956, is a medical doctor who embarked on a career path that blended regulatory oversight, pharmaceutical development, and entrepreneurship. He earned his Medical Degree from the University of Maryland, School of Medicine. His early experience included serving as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the FDA.

Rise to Success

Troendle's career included a stint at Sandoz (Novartis), where he was responsible for the clinical development of lipid-altering agents. Recognizing the need for high-quality clinical research services, he founded Medpace in Cincinnati, Ohio, in 1992. He served as President through July 31, 2021.

Key Business Strategies

Troendle's leadership has been key to Medpace's growth. Medpace offers comprehensive solutions for drug and medical device testing. He owns nearly 20% of Medpace stock. Medpace's 2024 revenues were approximately $2.11 billion.

Philanthropy

August Troendle is recognized for his philanthropy, supporting healthcare initiatives and research endeavors.

Career Milestones

1986-1987

Medical Review Officer

Worked in the Division of Metabolic and Endocrine Drug Products at the FDA

1987-1992

Manager

Worked at Sandoz (Novartis), responsible for the clinical development of lipid altering agents

1992

Founder of Medpace

Founded Medpace in Cincinnati, Ohio

Philanthropy & Social Impact

Healthcare

Healthcare Initiatives and Research

$XB

Supports healthcare initiatives and research endeavors in the Cincinnati community and beyond.